JP2023549075A5 - - Google Patents
Info
- Publication number
- JP2023549075A5 JP2023549075A5 JP2023526226A JP2023526226A JP2023549075A5 JP 2023549075 A5 JP2023549075 A5 JP 2023549075A5 JP 2023526226 A JP2023526226 A JP 2023526226A JP 2023526226 A JP2023526226 A JP 2023526226A JP 2023549075 A5 JP2023549075 A5 JP 2023549075A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063107182P | 2020-10-29 | 2020-10-29 | |
| US63/107,182 | 2020-10-29 | ||
| US202163143541P | 2021-01-29 | 2021-01-29 | |
| US63/143,541 | 2021-01-29 | ||
| US202163178286P | 2021-04-22 | 2021-04-22 | |
| US63/178,286 | 2021-04-22 | ||
| PCT/US2021/057443 WO2022094334A1 (en) | 2020-10-29 | 2021-10-29 | Use of an anti-cd19 antibody to treat autoimmune disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023549075A JP2023549075A (ja) | 2023-11-22 |
| JPWO2022094334A5 JPWO2022094334A5 (https=) | 2024-11-07 |
| JP2023549075A5 true JP2023549075A5 (https=) | 2024-11-07 |
Family
ID=81384348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526226A Pending JP2023549075A (ja) | 2020-10-29 | 2021-10-29 | 自己免疫疾患を治療するための抗ｃｄ１９抗体の使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230287114A1 (https=) |
| EP (1) | EP4237447A4 (https=) |
| JP (1) | JP2023549075A (https=) |
| KR (1) | KR20230097118A (https=) |
| AU (1) | AU2021368769A1 (https=) |
| CA (1) | CA3197022A1 (https=) |
| IL (1) | IL302294A (https=) |
| MX (1) | MX2023004794A (https=) |
| TW (1) | TW202233676A (https=) |
| WO (1) | WO2022094334A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023534916A (ja) * | 2020-06-30 | 2023-08-15 | ビエラ バイオ インコーポレイテッド | 視神経脊髄炎スペクトラム障害を治療する方法 |
| WO2025202213A1 (en) | 2024-03-26 | 2025-10-02 | Institut National de la Santé et de la Recherche Médicale | Lipid nanoparticle loaded with antitumoral agent and functionnalized to target immosuppressive cells |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201401465D0 (en) * | 2014-01-29 | 2014-03-12 | Roach Arthur H | Use of cladribine for treating autoimmune inflammatory disease |
| MX2021012870A (es) * | 2019-04-24 | 2022-01-18 | Viela Bio Inc | Uso de un anticuerpo anti cúmulo de diferenciación 19 (cd19) para tratar enfermedades autoinmunitarias. |
| JP2023534916A (ja) * | 2020-06-30 | 2023-08-15 | ビエラ バイオ インコーポレイテッド | 視神経脊髄炎スペクトラム障害を治療する方法 |
-
2021
- 2021-10-29 JP JP2023526226A patent/JP2023549075A/ja active Pending
- 2021-10-29 CA CA3197022A patent/CA3197022A1/en active Pending
- 2021-10-29 EP EP21887669.6A patent/EP4237447A4/en active Pending
- 2021-10-29 IL IL302294A patent/IL302294A/en unknown
- 2021-10-29 AU AU2021368769A patent/AU2021368769A1/en active Pending
- 2021-10-29 WO PCT/US2021/057443 patent/WO2022094334A1/en not_active Ceased
- 2021-10-29 MX MX2023004794A patent/MX2023004794A/es unknown
- 2021-10-29 TW TW110140391A patent/TW202233676A/zh unknown
- 2021-10-29 KR KR1020237018007A patent/KR20230097118A/ko active Pending
-
2023
- 2023-04-19 US US18/303,303 patent/US20230287114A1/en active Pending